Build Your Own Panel of Up to 21 Human Protein Biomarkers From a Pre-Validated Library of ∼ 200 Assays Covering Major Disease Areas
Vertex and CRISPR Therapeutics Announce MHRA Marketing Authorisation Application Validation for CRISPR/Cas9 Gene-Edited Therapy
The Medicines and Healthcare products Regulatory Agency has validated the Marketing Authorisation Application of exa-cel for the treatment of sickle cell disease and transfusion-dependent beta thalassemia in Great Britain.
Personalis and Moderna Sign New Agreement To Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials
The platform will be used to sequence genomic information from a patient’s tumor sample to identify the unique genetic mutations that are most likely to generate a tailored antitumor response.
German Pharma Company Selects Generis’ CARA Life Sciences Platform To Unify Their Clinical Processes
German Pharma company Cheplapharm has selected the CARA Life Science Platform to standardize and unify their Regulatory, RIM, Quality and Labelling processes across departmental boundaries.
GenNext Technologies Announces the Appointment of Dr. John Grant to its Board of Directors
GenNext Technologies, Inc. has announced that Dr. John L. Grant has joined its Board of Directors.
TTP Introduces Cellular Origins, a TTP Company Focused on Delivering Scalable Manufacture of Cell and Gene Therapies
TTP plc has today announced the launch of Cellular Origins, a TTP spin-out, created to enable scalable, cost-effective and efficient manufacture of cell and gene therapies.
FUJIFILM Irvine Scientific Launches HEK293 Feed, Specifically Designed for Viral Vector Production
FUJIFILM Irvine Scientific, Inc. has announced the launch of its BalanCD HEK293 Viral Feed.
Pheno Therapeutics Announces Worldwide License From UCB to a Novel Program for Neurodegenerative Disease
Pheno Therapeutics Limited has announced that it has entered into an exclusive worldwide license agreement with UCB.
Investigating Glycans – Shedding New Light on the "Dark Matter" of Biology
AMSBIO reports how the Faculty of Biological Sciences at the University of Leeds (UK) is using their specialty reagents for the production, visualization and analysis of glycans and to investigate their interactions which are instrumental to the advance of glycobiology.
Fraunhofer IZI Selects Lonza’s MODA-ES® Solution To Digitalize Manufacturing Operations
Fraunhofer IZI intends to digitalize its manufacturing operations with MODA-ES®, the Manufacturing Execution System from Lonza.
MaxCyte Signs Strategic Platform License With Curamys To Enable Cell and Gene Therapies for the Treatment of Rare Intractable Diseases
Under the terms of the agreement, Curamys obtains non-exclusive clinical and commercial rights to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform.